Makerere University: Clinical Trials

36 trials sponsored by Makerere University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 13 unknown, 4 recruiting, 2 not yet recruiting. 36 Phase 2, 14 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 236Completed 14, Unknown 13, Recruiting 4, Not yet recruiting 2, Terminated 2, Enrolling by invitation 1
Phase 314Completed 6, Unknown 5, Recruiting 2, Terminated 1
Phase 15Not yet recruiting 2, Completed 1, Recruiting 1, Terminated 1

Follow Makerere University: new trials by email

Trials (filtered) newest first · largest first

All 36 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Game Changers for Family Planning Peer Advocacy Program
Game Changers for Family Planning - Family Planning
Phase 1 / Phase 2Not yet recruitingRAND1922027-11-152025-12-31
Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
hydroxycarbamide - Sickle Cell Disease, Sickle Cell Anemia in Children
Phase 1 / Phase 2RecruitingChildren's Hospital Medical Center, Cincinnati2502026-05-132026-07-16
Efficacy Testing of a Multi-Level Family Planning Intervention
Family Planning Intervention, Water, Sanitation, and Hygiene (WASH) Intervention - Unintended Pregnancy, Family Planning
Phase 2 / Phase 3RecruitingBoston College14642025-06-122026-03-23
Zinc for Infection Prevention in Sickle Cell Anemia-2 (ZIPS-2)
zinc sulfate, Placebo - Sickle Cell Disease
Phase 2 / Phase 3CompletedIndiana University1002025-02-102026-01-30
Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline
Doxycycline, Placebo - Tuberculosis, Pulmonary
Phase 2RecruitingMakerere University2002024-12-042025-04-17
Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services
Peer distribution of self testking kits - HIV, Syphilis
Phase 2Enrolling by invitationMakerere University2002024-08-252025-01-24
Solidarity/Tokomeza Ebola Trial
CAd3, ChAdox1, rVSV-SUDV - Sudan Ebola Virus Vaccines
Phase 1 / Phase 2Not yet recruitingMakerere University21212023-07-012023-06-18
Clinical Trial of Natural Therapeutics for COVID-19 and Other Acute Respiratory Viral Infections
TAZCOV, Vidicine - Acute Respiratory Infection
Phase 2UnknownMakerere University5102023-03-032023-06-09
Safety and Efficacy of COVIDEX™ Therapy in Management of Adult COVID-19 Patients in Uganda.
COVIDEX - COVID-19
Phase 2UnknownMakerere University5842022-03-012022-03-02
Pharmacogenetics-guided Isoniazid Dosing in TB-HIV
Isoniazid Tablets - Tuberculosis
Phase 2UnknownMakerere University402021-12-072022-01-25
Promoting Cervical Cancer Screening Through the Advocacy of Screened Women
WOMEN FIGHTING TO STOP CERVICAL CANCER - Cervical Cancer Prevention
Phase 2CompletedRAND1432021-08-302022-04-27
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
Pancreatic Enzyme, Ursodeoxycholic acid, Pancreatic Enzyme placebo - SEPSIS, MALNUTRITION, CHILD
Phase 2 / Phase 3UnknownUniversity of Oxford4002021-07-012023-02-24
Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition
Ceftriaxone Sodium, Ampicillin, Gentamicin - HIV-1-infection, Malnutrition, Child
Phase 2 / Phase 3UnknownMakerere University3002021-06-142021-09-30
Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy
Remdesivir - Ebola, HIV/AIDS
Phase 2CompletedMakerere University242021-05-052021-08-25
Efficacy of Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids
Autologous Adipose Derived stem cell transplantation, Triamcinolone Acetonide 40Mg/Ml Inj,Susp_#1 - Adipose Derived Stem Cells, Keloid
Phase 2UnknownMakerere University302021-05-012021-06-18
Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids.
Autologous adipose derived stem cells - Keloid, Autologus Adipose Derived Stem Cells
Phase 2CompletedMakerere University82021-03-012021-06-18
Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients
3-dayIVM 200 mcg/kg/day/14-day 75mgASA/day + standard of care (intervention 1) - Covid19
Phase 2 / Phase 3UnknownMakerere University4902021-02-192021-02-24
Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Dose escalation - HIV/AIDS, Tuberculosis
Phase 2 / Phase 3CompletedUniversity of Liverpool262020-10-302024-07-12
Hydroxychloroquine for Treatment of Non-Severe COVID-19
Hydroxychloroquine tablets - Covid19
Phase 2UnknownMakerere University1052020-09-182021-04-26
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia
Valganciclovir Oral Solution [Valcyte], Tuberculostatic Agents - Pneumonia, HIV/AIDS
Phase 2 / Phase 3CompletedHospital Universitario 12 de Octubre5632020-03-012025-09-19

Showing 20 of 36. Sign in to see all of them.

Conditions studied

Acquired Immunodeficiency Syndrome (4)  ·  Tuberculosis (4)  ·  Anemia, Sickle Cell (3)  ·  COVID-19 (3)  ·  Child Nutrition Disorders (2)  ·  Keloid (2)  ·  AIDS Dementia Complex (1)  ·  Breast Feeding (1)  ·  Cicatrix (1)  ·  Critical Illness (1)  ·  Cytomegalovirus Infections (1)  ·  Depression (1)  ·  Dysbiosis (1)  ·  HIV Infections (1)  ·  Hemorrhagic Fever, Ebola (1)

Interventions

Doxycycline (2)  ·  Levonorgestrel (2)  ·  Rilpivirine (2)  ·  Standard of Care (2)  ·  efavirenz (2)  ·  Amphotericin B (1)  ·  Ampicillin (1)  ·  Antitubercular Agents (1)  ·  Ceftriaxone (1)  ·  Darunavir (1)  ·  Dexamethasone (1)  ·  Drug Implants (1)  ·  Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Family Planning Services (1)  ·  Fluconazole (1)

Countries

Uganda (32)  ·  Malawi (2)  ·  Bangladesh (1)  ·  Côte d’Ivoire (1)  ·  France (1)  ·  Italy (1)  ·  Kenya (1)  ·  Mozambique (1)  ·  Netherlands (1)  ·  South Africa (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  Zambia (1)  ·  Zimbabwe (1)

Top investigators

Christine Sekaggya-Wiltshire, MBChB, PhD (2)  ·  Mohammed Lamorde, PhD (2)  ·  Allen Nalugwa, PhD (1)  ·  Annette Olsen, PhD (1)  ·  Anthony Okoth, MMed (1)  ·  Barbara A Castelnuovo, MD, MPH. PhD (1)  ·  Chandy C John, MD (1)  ·  Christine Namata, MBChB (1)  ·  Cinta Moraleda, MD, PhD (1)  ·  Edridah Muheki, PhD (1)  ·  Fred Nuwaha, PhD (1)  ·  Glenn Wagner (1)  ·  Glenn Wagner, PhD (1)  ·  Jackson Mukonzo, PhD (1)  ·  James A Berkley, MD (1)

Results publications

PMID 10190913, PMID 10501745, PMID 11807470, PMID 12663340, PMID 15069048, PMID 19295939, PMID 21745716, PMID 21752262, PMID 25393993, PMID 26510464, PMID 26646680, PMID 2682703, PMID 27814710, PMID 28316259, PMID 29370261, PMID 29382251, PMID 29448936, PMID 29467010, PMID 29499740, PMID 29799555, PMID 30841858, PMID 31277180, PMID 31539371, PMID 32054536, PMID 33346335, PMID 34814933, PMID 34872511, PMID 35761406, PMID 35813373, PMID 35861296, PMID 36127627, PMID 36476609, PMID 36724434, PMID 36907945, PMID 37489818, PMID 37656308, PMID 37702912, PMID 37885364, PMID 37982585, PMID 38754459, PMID 39044381, PMID 39301593, PMID 40018208, PMID 40188047, PMID 40307889, PMID 42016921, PMID 42468541, PMID 42616536, PMID 42643234, PMID 9036320

NIH funding

2019 (1), R01HD113806 (1), R21HD074462 (1)